Generic Sweden Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 6/6

Generic Sweden hat ein Gesamteigenkapital von SEK46.1M und eine Gesamtverschuldung von SEK0.0, wodurch sich der Verschuldungsgrad auf 0% beläuft. Die Gesamtaktiva und Gesamtpassiva betragen SEK78.4M bzw. SEK32.3M. Generic Sweden Das EBIT des Unternehmens beträgt SEK28.9M, so dass der Zinsdeckungsgrad -31.8 beträgt. Das Unternehmen verfügt über Barmittel und kurzfristige Anlagen in Höhe von SEK33.7M.

Wichtige Informationen

0%

Verhältnis von Schulden zu Eigenkapital

SEK 0

Verschuldung

Zinsdeckungsgrad-31.8x
BargeldSEK 33.65m
EigenkapitalSEK 46.08m
GesamtverbindlichkeitenSEK 32.35m
GesamtvermögenSEK 78.43m

Jüngste Berichte zur Finanzlage

Keine Aktualisierungen

Recent updates

Generic Sweden's (STO:GENI) Profits May Not Reveal Underlying Issues

Aug 29
Generic Sweden's (STO:GENI) Profits May Not Reveal Underlying Issues

Some Confidence Is Lacking In Generic Sweden AB (STO:GENI) As Shares Slide 29%

Feb 25
Some Confidence Is Lacking In Generic Sweden AB (STO:GENI) As Shares Slide 29%

Generic Sweden's (STO:GENI) Solid Earnings May Rest On Weak Foundations

Feb 22
Generic Sweden's (STO:GENI) Solid Earnings May Rest On Weak Foundations

Do Generic Sweden's (STO:GENI) Earnings Warrant Your Attention?

Feb 19
Do Generic Sweden's (STO:GENI) Earnings Warrant Your Attention?

Should You Investigate Generic Sweden AB (STO:GENI) At kr60.20?

Jan 11
Should You Investigate Generic Sweden AB (STO:GENI) At kr60.20?

Is Now The Time To Look At Buying Generic Sweden AB (STO:GENI)?

Sep 16
Is Now The Time To Look At Buying Generic Sweden AB (STO:GENI)?

Should You Be Adding Generic Sweden (STO:GENI) To Your Watchlist Today?

Jul 01
Should You Be Adding Generic Sweden (STO:GENI) To Your Watchlist Today?

Is Generic Sweden AB (STO:GENI) Potentially Undervalued?

Feb 18
Is Generic Sweden AB (STO:GENI) Potentially Undervalued?

We Ran A Stock Scan For Earnings Growth And Generic Sweden (STO:GENI) Passed With Ease

Aug 26
We Ran A Stock Scan For Earnings Growth And Generic Sweden (STO:GENI) Passed With Ease

A Look At The Intrinsic Value Of Generic Sweden AB (STO:GENI)

Apr 28
A Look At The Intrinsic Value Of Generic Sweden AB (STO:GENI)

Is It Time To Consider Buying Generic Sweden AB (STO:GENI)?

Apr 08
Is It Time To Consider Buying Generic Sweden AB (STO:GENI)?

Is Now The Time To Put Generic Sweden (STO:GENI) On Your Watchlist?

Feb 18
Is Now The Time To Put Generic Sweden (STO:GENI) On Your Watchlist?

Calculating The Fair Value Of Generic Sweden AB (STO:GENI)

Jan 10
Calculating The Fair Value Of Generic Sweden AB (STO:GENI)

With EPS Growth And More, Generic Sweden (STO:GENI) Is Interesting

Nov 08
With EPS Growth And More, Generic Sweden (STO:GENI) Is Interesting

Here's Why I Think Generic Sweden (STO:GENI) Is An Interesting Stock

Jul 17
Here's Why I Think Generic Sweden (STO:GENI) Is An Interesting Stock

Here's Why I Think Generic Sweden (STO:GENI) Might Deserve Your Attention Today

Apr 13
Here's Why I Think Generic Sweden (STO:GENI) Might Deserve Your Attention Today

Is Generic Sweden AB (STO:GENI) A Smart Pick For Income Investors?

Mar 26
Is Generic Sweden AB (STO:GENI) A Smart Pick For Income Investors?

A Look At The Intrinsic Value Of Generic Sweden AB (STO:GENI)

Mar 04
A Look At The Intrinsic Value Of Generic Sweden AB (STO:GENI)

Should You Take Comfort From Insider Transactions At Generic Sweden AB (STO:GENI)?

Feb 14
Should You Take Comfort From Insider Transactions At Generic Sweden AB (STO:GENI)?

Will Weakness in Generic Sweden AB's (STO:GENI) Stock Prove Temporary Given Strong Fundamentals?

Jan 26
Will Weakness in Generic Sweden AB's (STO:GENI) Stock Prove Temporary Given Strong Fundamentals?

Here's Why I Think Generic Sweden (STO:GENI) Might Deserve Your Attention Today

Jan 05
Here's Why I Think Generic Sweden (STO:GENI) Might Deserve Your Attention Today

Is There More To The Story Than Generic Sweden's (STO:GENI) Earnings Growth?

Dec 16
Is There More To The Story Than Generic Sweden's (STO:GENI) Earnings Growth?

Does Generic Sweden AB (STO:GENI) Have A Place In Your Dividend Portfolio?

Nov 25
Does Generic Sweden AB (STO:GENI) Have A Place In Your Dividend Portfolio?

Analyse der Finanzlage

Kurzfristige Verbindlichkeiten: GENIDie kurzfristigen Aktiva des Unternehmens (SEK70.4M) übersteigen seine kurzfristigen Passiva (SEK26.0M).

Langfristige Verbindlichkeiten: GENIDie kurzfristigen Vermögenswerte des Unternehmens (SEK70.4M) übersteigen seine langfristigen Verbindlichkeiten (SEK6.3M).


Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Verschuldungsgrad: GENI ist schuldenfrei.

Schulden abbauen: GENI hat in den letzten 5 Jahren keine Schulden gemacht.

Schuldendeckung: GENI hat keine Schulden und muss daher nicht durch den operativer Cashflow gedeckt werden.

Zinsdeckung: GENI hat keine Schulden, daher ist die Deckung der Zinszahlungen kein Problem.


Bilanz


Entdecken Sie finanziell stabile Unternehmen